Wei Lin

Insider Reports History

Location
San Diego, CA
Signature
/s/ Jack Anders, as Attorney-in-fact for Wei Lin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Wei Lin:

Form 4 holding Chief Medical Officer

Erasca, Inc.

Security class
Common Stock
Shares / value
315,812
Estimated value
$501,983
Report date
01 Feb 2023
Price
$1.59
Ownership
Direct
Form 4 holding Director

2seventy bio, Inc.

Security class
Stock Options (Right to buy)
Shares / value
24,100
Estimated value
$94,713
Report date
10 Jun 2024
Price
$3.93
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Medical Officer

Erasca, Inc.

Security class
Stock Option (right to buy)
Shares / value
560,000
Estimated value
Report date
01 Feb 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

2seventy bio, Inc.

Security class
Stock Options (Right to buy)
Shares / value
0
Estimated value
Report date
13 May 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Wei Lin

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .